Evidence-based prediction and prevention of cardiovascular morbidity in adults treated for cancer.

ABSTRACT:

Background

Cancer treatment-related morbidity relevantly compromises health status in cancer survivors, and efforts to optimise health-related outcomes in this population are vital to maximising healthy survivorship. A pre-treatment assessment - and possibly preventive management strategies - of cancer patients at increased risk for cardiovascular disease (CVD) seems a rational approach in this regard. Definitive evidence for such strategies is largely lacking, thereby impeding the formulation of firm recommendations.

Results

The current scoping review aims to summarise and grade the evidence regarding strategies for prediction and prevention of CVD in adults in relation to oncological treatments. We conducted a scoping literature search for different strategies for primary

SUBMITTER: Altena R 

PROVIDER: S-EPMC8161987 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature